RxDoctor Payments Data

Laura Johnston, NP

Family · Columbia, SCNPI 1972078863

Payments from drug & device makers

$407in general payments, 2019–2025

Across 18 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$120
  • Bioxcel Therapeutics, Inc.$112
  • AstraZeneca$76
  • Pfizer$27
  • Takeda Pharmaceuticals U.S.A., Inc.$18
  • Novo Nordisk$16
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$39597%
  • Education$123%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$407 in reported general payments places this provider in the 45th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$55,662
Medicare patients
209
Services billed
1,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$28,964
JardianceEmpagliflozin24$25,529
EliquisApixaban22$18,932
FarxigaDapagliflozin Propanediol13$13,418
LinzessLinaclotide22$12,422
BelsomraSuvorexant13$5,494
Humalog Kwikpen U-100Insulin Lispro12$5,091
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$3,107
Rosuvastatin Calcium127$2,788
TirosintLevothyroxine Sodium11$2,391
Esomeprazole Magnesium23$1,998
Omeprazole98$1,676
Levothyroxine Sodium138$1,637
Testosterone11$1,308
Lisinopril118$1,260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$28,96421 claims
PfizerEliquis$27$18,93222 claims
AstraZenecaFarxiga$76$13,41813 claims
AbbVieLinzess$120$12,42222 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$12$1,637138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →